Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants

Citation
Jm. Groarke et Dc. Pevear, Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants, J INFEC DIS, 179(6), 1999, pp. 1538-1541
Citations number
15
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
179
Issue
6
Year of publication
1999
Pages
1538 - 1541
Database
ISI
SICI code
0022-1899(199906)179:6<1538:AVOPCB>2.0.ZU;2-4
Abstract
Pleconaril (VP 63843) is a novel orally bioavailable small molecule with br oad antipicornavirus (enterovirus and rhinovirus) activity, Ten independent ly derived pleconaril-resistant variants of coxsackievirus B3 were isolated from cell culture. The molecular basis of drug resistance and the biologic properties of the drug-resistant viruses were investigated. RNA sequence a nalysis revealed amino acid changes in the drug-binding pocket of the resis tant variants. Thermal stability studies showed the drug-resistant viruses to be significantly less stable than wild type virus. When evaluated in a m urine model in which wild type virus infection is 100% lethal, the drug-res istant viruses showed attenuated virulence with both reduced mortality and delayed time to death. Virus titers in heart and spleen were dramatically l ower in drug-resistant virus-infected mice than in wild type virus-infected animals. The study results indicate that pleconaril-resistant virus varian ts are attenuated and significantly less virulent than drug-sensitive wild type virus.